type 1 diabetes glp 1 Glucagon-like peptide-1 In type 1 patients with
Description
This condition not only affects appearance but can also impair medication absorption, potentially reducing therapeutic efficacy
Comparison with peers and trials
Many of these drugs feature novel mechanisms of action or routes of administration and this increased competition may eventually exert downward pressure on pricing
PMID: 31530666
